Quantinno Capital Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3M Buy
546,694
+470,119
+614% +$13.9M 0.02% 723
2026
Q1
$2.12M Buy
76,575
+10,064
+15% +$259K ﹤0.01% 1585
2025
Q4
$1.44M Buy
66,511
+15,078
+29% +$297K ﹤0.01% 1531
2025
Q3
$778K Buy
51,433
+19,760
+62% +$245K ﹤0.01% 1642
2025
Q2
$357K Buy
31,673
+6,333
+25% +$68.6K ﹤0.01% 1894
2025
Q1
$256K Buy
+25,340
New +$274K ﹤0.01% 1717

Other funds holding ROIV

Quantinno Capital Management's ROIV Position: Q2 2026 in Review

Quantinno Capital Management increased its Roivant Sciences (ROIV) stake by 614% in Q2 2026, buying an estimated $13.9M and bringing the position to 546,694 shares worth $19.3M. The position accounts for 0.02% of the portfolio, ranked #723.

Quantinno Capital Management first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Quantinno Capital Management held 546,694 shares of Roivant Sciences worth $19.3M as of Q2 2026.
  • Quantinno Capital Management bought 470,119 Roivant Sciences shares in Q2 2026, an estimated $13.9M.
  • Roivant Sciences made up 0.02% of Quantinno Capital Management's portfolio in Q2 2026, its #723 holding.
  • Quantinno Capital Management first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.